Navigation Links
Citalopram, a Boon in Treating Depressed Heart Patients

Canadian researchers have come out with findings from a study that indicates the superiority of selective serotonin reuptake inhibitors (SSRIs) like celexa in combating// depression.

Dr. Fran?ois Lespérance, a psychiatrist at the University of Montreal and his colleagues published their findings in this week’s edition of the Journal of the American Medical Association.

The drug celexa, which goes by the generic name citalopram, is prescribed for patients suffering from major depression that lasts more than two weeks.

Depression is commonly associated with coronary heart disease or CAD. Around 17 to 27 percent of CAD diagnosed patients are found to suffer from depression.

The study involved 284 CAD patients and lasted a period of 12 weeks.

They were asked to undergo three modes of treatment: half to take clinical management with or without psychotherapy sessions and the other half to take the drug celexa or a placebo.

Clinical management included doctor visits to discuss depression and medication use, provide reassurance, and inquire about patients' symptoms. Psychotherapy took place immediately after the clinical management sessions, and dealt with problems such as interpersonal conflicts, life transitions, grief and loss, and social isolation.

The results observed showed that there was reduction in depression symptoms by half as compared with that of the control patients, while surprisingly psychotherapy sessions did not show any reduction in depression.

Standardized depression scores were 67 percent more likely to drop by half on citalopram than placebo, and the chance of depression remitting was almost doubled.

Says Dr. Lesperance, "Citalopram or sertraline, as previously shown in [a different trial], plus clinical management should be considered for the initial acute-phase treatment for major depression in patients with coronary artery disease.”

Physicians Alexan der Glassman and J. Thomas Bigger of the New York State Psychiatric Institute who opine that the study provides further evidence that SSRIs combat depression in heart disease victims support the authors’ findings.
NN
'"/>




Related medicine news :

1. Treating eye pain eases migraine
2. Treating wounds without stitches
3. Treating varicose veins
4. Treating acne with laser
5. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
6. Treating Stroke Patients in Rural Areas
7. Free Tissue Transfer Effective in Treating Massive Skin Cancers
8. Treating Blocked Arteries In The Lower Limbs
9. Zinc Supplements Found To Be Effective In Treating Children With ADHD
10. Hormone Leptin Found To Be Effective In Treating Women With Infertility Problems
11. Treating Depression In Children Could Lead To Poor Bone Development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... InDemand Interpreting , ... recently partnered with Heart City Health Center to improve access to ... Heart City Health Center has provided the Elkhart community with access to high ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to stabilize critical ... leave patients with dental emergencies at risk of losing a tooth or their smiles. ... , Common dental emergencies include:, , Avulsed or knocked-out ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Ongoing news of ... Life Care Association™ (ALCA) to conduct a survey that takes a closer look at ... today illustrates the prevalence and causes of TBI among the aging population, and identifies ...
(Date:2/10/2016)... , ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: ... report results for the fourth quarter and full year ended December 31, 2015 on ... conference call and webcast for the investment community following the release at 4:30 PM ...
(Date:2/10/2016)... ... 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves ... The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp explains ... is March 16, 2016. A free review copy is available to the media ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... MOUNTAIN VIEW, Calif. , Feb. 10, ... result of a synergistic confluence of various ... unique value propositions, previously unavailable. These opportunities ... convergence and convergence, in turn, drives the ... Today,s entrepreneurial scenario is characterized by technology ...
(Date:2/10/2016)... Jersey and OR AKIVA, Israel ... Regentis Biomaterials Ltd., a leader in the ... Series D investment round on February 5, 2016. The ... Group ("Haisco"), a leading Chinese pharmaceutical manufacturer, and ... SCP Vitalife Partners, Generali Financial Holdings and both the ...
(Date:2/10/2016)... ALSP, Inc. announced that it has appointed Col.(Retired) Dallas ... preparation for its move into clinical trials with its lead ... are pleased to welcome Dallas Hack onto the ... of such practical knowledge and far-reaching experience in Traumatic Brain ... broad experience and success as a clinician and researcher in ...
Breaking Medicine Technology: